Louise Emmett, Nuclear Medicine and PET specialist at St Vincent’s Public Hospital Sydney, shared on LinkedIn:
“6 doses PSMA-RLT 6 weekly?
Is that all we’ve got?
Are we undertreating?
We should know pretty soon…
Dose-intensified PSMA Radioligand Therapy: The Rationale Behind the OPTIMAL-PSMA Trial: A mini-review in European Urology Focus.”
Title: Dose-intensified PSMA Radioligand Therapy: The Rationale Behind the OPTIMAL-PSMA Trial
Authors: Gemma Sheehan-Dare, Sobia Khan, Louise Emmett
Other articles about Radioligand Therapy and prostate cancer on OncoDaily.